based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts offering long term price targets for J B Chemicals & Pharmaceuticals Ltd. An average target of ₹2118
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd price forecast by 13 analysts
Upside of11.98%
High
₹2343
Target
₹2118.00
Low
₹1651
J B Chemicals & Pharmaceuticals Ltd target price ₹2118, a slight upside of 11.98% compared to current price of ₹1906.05. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
J B Chemicals & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2026:31.38%
Forecast
Actual
Including amortisation and stock based compensations
J B Chemicals & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2026:58.16%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.11 % |
3 Month Return | + 4.38 % |
1 Year Return | + 46.92 % |
Market Stats | |
Previous Close | ₹1,891.35 |
Open | ₹1,902.00 |
Volume | 1.22L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹29,375.39Cr |
P/E Ratio | 49.84 |
PEG Ratio | 3.65 |
Market Cap | ₹29,375.39 Cr |
P/B Ratio | 8.87 |
EPS | 35.61 |
Dividend Yield | 0.74 |
Sector | Pharmaceuticals |
ROE | 20.39 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹29,375.39 Cr | 190.27% | 0.56 | ₹552 Cr | ₹3,484 Cr | |
HOLD | ₹31,560.96 Cr | 127.13% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹18,791.82 Cr | 30.25% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹6,996.36 Cr | 12.52% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹14,535.09 Cr | 43.59% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | J B Chemicals & Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for J B Chemicals & Pharmaceuticals Ltd
Prabhudas Lilladher projects strong domestic growth for J B Chemicals & Pharma, driven by brand expansion and increased productivity. The firm anticipates an EBITDA CAGR of 18% and EPS CAGR of 23.5% from FY 2024 to 2027.
KKR Considers Market Exit for JB Chemicals Stake - 07 Oct, 2024
KKR is exploring the option of exiting its stake in JB Chemicals and Pharmaceuticals through market sales, as discussions over valuation have stalled. The $2 billion deal has faced challenges due to high valuation, with limited interest from drug manufacturers.
JM Financial Recommends Buy on J B Chemicals - 30 Sep, 2024
JM Financial has issued a buy recommendation for J B Chemicals & Pharmaceuticals, setting a target price of Rs 2,210. The company reported a consolidated total income of Rs 1,010.29 crore for Q2 2024, reflecting a 15.02% increase from the previous quarter. Net profit after tax stood at Rs 176.83 crore, with promoters holding 53.77% of the stake.
JB Chemicals Shares Drop Amid KKR Stake Sale Concerns - 25 Sep, 2024
On September 25, JB Chemicals shares fell 4.5% as news emerged that KKR's sale of its 54% stake may collapse over valuation disagreements, impacting investor sentiment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 851.86 Cr → 1.01K Cr (in ₹), with an average increase of 8.0% per quarter
Price Rise
In the last 7 days, JBCHEPHARM stock has moved up by 3.3%
Profit Spike
Netprofit is up for the last 2 quarters, 126.16 Cr → 176.83 Cr (in ₹), with an average increase of 28.7% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 12.17% to 13.63% in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 16.43% to 15.81% in Sep 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 53.77% to 53.74% in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 15.04% to 14.60% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 53.74% | ||
Foreign Institutions | 13.63% | 12.03 | |
Mutual Funds | 14.6% | ||
Retail Investors | 15.81% | ||
Others | 2.21% |
J B Chemicals & Pharmaceuticals Ltd in the last 5 years
Lowest (10.61x)
October 24, 2019
Today (49.84x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (62.92x)
February 7, 2024
J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 24.25% since last year same period to ₹176.83Cr in the Q1 2024-2025. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated 40.16% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹6.75 - translating a dividend yield of 1.14%.
Read More about DividendsBearish
Neutral
Bullish
J B Chemicals & Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price today is ₹1906.05
J B Chemicals & Pharmaceuticals Ltd is listed on NSE
J B Chemicals & Pharmaceuticals Ltd is listed on BSE
PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 49.84
PE ratio = J B Chemicals & Pharmaceuticals Ltd Market price per share / J B Chemicals & Pharmaceuticals Ltd Earnings per share
Today’s traded volume of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is 1.22L.
Today’s market capitalisation of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is ₹29375.39Cr.
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Price |
---|---|
52 Week High | ₹2030 |
52 Week Low | ₹1244.45 |
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1906.05. It is down -6.11% from its 52 Week High price of ₹2030
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1906.05. It is up 53.16% from its 52 Week Low price of ₹1244.45
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Returns |
---|---|
1 Day Returns | 14.7% |
1 Month Returns | -3.11% |
3 Month Returns | 4.38% |
1 Year Returns | 46.92% |